apl. Prof. Dr. Stefan Krause

Medizinische Fakultät Department of Medicine 5 – Haematology and Oncology

Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study (2016) Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, et al. Journal article Karyotype complexity and prognosis in acute myeloid leukemia (2016) Stoelzel F, Mohr B, Kramer M, Oelschlaegel U, Bochtler T, Berdel WE, Kaufmann M, et al. Journal article Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial (2016) Ferreri AJM, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, et al. Journal article Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV (2016) Miranda MB, Lauseker M, Kraus MP, Proetel U, Hanfstein B, Fabarius A, Baerlocher GM, et al. Journal article High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study) (2016) Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Moehle R, Loew S, et al. Journal article Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study (2016) Boch T, Spiess B, Cornely OA, Vehreschild JJ, Rath PM, Steinmann J, Heinz WJ, et al. Journal article Topotecan plus cyclophosphamide in adults with relapsed or refractory pediatric-type sarcoma: a retrospective analysis from the German Sarcoma Medical Oncology Group (AIO) (2015) Hartmann JT, Issels RD, Nicolo KS, Gruenwald V, Hertenstein B, Papesch E, Krause S, Sturm I Journal article Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML (2015) Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Goehring G, et al. Journal article Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV (2015) Saussele S, Krauss MP, Hehlmann R, Lauseker M, Proetel U, Kalmanti L, Hanfstein B, et al. Journal article Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV (2015) Kalmanti L, Saussele S, Lauseker M, Mueller MC, Dietz CT, Heinrich L, Hanfstein B, et al. Journal article